Latest Breaking News On - Generation bio - Page 3 : comparemela.com

Moderna, Inc (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript

Moderna, Inc. beats earnings expectations. Reported EPS is $-3.07, expectations were $-3.56.

United statesNew yorkSalveen richterMichael yeeTerence flynnEllie merleLavina talukdarStephen hogeModerna incGoldman sachsMorgan stanleyMinistry of healthCall transcript mayFirst quarterChief executive officerJamey mock

Brokerages Set Generation Bio Co (NASDAQ:GBIO) Price Target at $8 00

Brokerages Set Generation Bio Co (NASDAQ:GBIO) Price Target at $8 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Los angelesUnited statesGeneration bio company profileTd asset management incSg americas securitiesKestra private wealth servicesLos angeles capital managementNeedham companyGeneration bio coGeneration bioGet free reportMarketbeat ratingsManagement incAngeles capital managementAsset managementGet free

Moderna, Inc : Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates

Moderna, Inc : Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomChris ridleySanofi pasteurLavina talukdarMerck keytrudaBlackstone life sciencesLinkedin top companiesMerck sharp dohme corpExchange commissionModerna incDevelopment expensesEuropean unionMinistry of healthEu health emergencyResponse authorityCompany accolade

Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates

Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 expected product sales of approximately $4 billionInitiated three new clinical studies evaluating Moderna's investigational.

United kingdomLavina talukdarMerck keytrudaChris ridleySanofi pasteurResponse authorityCompany accoladeEu health emergencyMinistry of healthEuropean unionDevelopment expensesModerna incExchange commissionMerck sharp dohme corpLinkedin top companiesBlackstone life sciences

Moderna (MRNA) Q1 2024 Earnings Call Transcript

MRNA earnings call for the period ending March 31, 2024.

United statesNew yorkTed tenthoff piper sandlerMike yee jefferiesMichael yeeStephen hogeEdward tenthoffBevan wangHartaj singh oppenheimerSalveen richter goldman sachsGena wangRedburn atlanticTerence flynn morgan stanleySimon bakerEllie merleSimon baker redburn atlantic